This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
New York-based Coty Inc., along with its subsidiaries, manufactures, markets, and distributes beauty products worldwide. The company sells its products through retailers, including hypermarkets, supermarkets, independent and chain drug stores and pharmacies, upscale perfumeries, upscale and mid-tier department stores, nail salons, specialty retailers, duty-free shops and traditional food, and drug and mass retailers. It also markets products under the Astor, Coty, Joop!, Jovan, Manhattan, and N.Y.C. New York Color brands.
EL Trading Near 52-Week Low: How Should Investors Approach the Stock?
by Ansuiya Mohta
EL is battling weak consumer sentiment, market instability and currency woes. The company is making some progress with its Profit Recovery and Growth Plan.
Coty Thrives in the Growing Beauty Space Despite Cost Challenges
by Zacks Equity Research
COTY continues to benefit from robust growth in the global beauty market, driven by a strong brand presence and consumer demand.
Coty (COTY) Reliance on International Sales: What Investors Need to Know
by Zacks Equity Research
Review Coty's (COTY) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
COTY's Q4 Loss Wider Than Estimates, Sales Increase Y/Y
by Zacks Equity Research
COTY's fourth-quarter fiscal 2024 results reflect growth in the Consumer Beauty segments. However, the bottom line declines year over year.
Coty (COTY) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Coty (COTY) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Coty (COTY) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
Coty (COTY) delivered earnings and revenue surprises of -175% and 0.94%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Estee Lauder (EL) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Estee Lauder (EL) delivered earnings and revenue surprises of 156% and 0.99%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
COTY Gears Up for Q4 Earnings Release: Things to Keep in Mind
by Zacks Equity Research
COTY's fiscal fourth-quarter performance is likely to reflect gains from momentum in the global beauty market. However, a rising cost environment might be a hurdle.
What Analyst Projections for Key Metrics Reveal About Coty (COTY) Q4 Earnings
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Coty (COTY), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.
4 Cosmetics Stocks Worth Watching Amid Industry Challenges
by Ansuiya Mohta
The Zacks Cosmetics industry is grappling with elevated inflationary pressures. Coty, Inter Parfums (IPAR), Waldencast (WALD) and Olaplex (OLPX) are capitalizing on digital advancements and innovative strategies.
Flowers Foods (FLO) Q2 Earnings in the Cards: Things to Note
by Zacks Equity Research
Flowers Foods' (FLO) second-quarter 2024 performance is likely to reflect gains from portfolio strength, while high SD&A costs and a volatile consumer landscape are concerns.
Coty (COTY) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Coty (COTY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BRF S.A. (BRFS) Q2 Earnings in the Cards: Things to Consider
by Zacks Equity Research
BRF S.A.'s (BRFS) second-quarter 2024 performance will likely reflect gains from the BRF+ program and stable feed costs.
E.l.f. Beauty (ELF) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
e.l.f. Beauty (ELF) delivered earnings and revenue surprises of 32.53% and 6.88%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Sally Beauty (SBH) Q3 Earnings in the Cards: Things to Note
by Zacks Equity Research
Sally Beauty's (SBH) third-quarter fiscal 2024 performance will likely reflect the adverse impact of a decline in customer traffic and inflationary pressures.
Nu Skin (NUS) Set to Report Q2 Earnings: What to Expect?
by Zacks Equity Research
Nu Skin's (NUS) Q2 results are likely to reflect the impacts of macroeconomic challenges, including inflation and adverse currency fluctuations.
Inter Parfums (IPAR) Q2 Earnings in the Cards: Things to Note
by Zacks Equity Research
Inter Parfums' (IPAR) second-quarter performance is likely to reflect strong momentum in the fragrance market, supported by robust sales from its new licenses. High SG&A costs are a threat.
Monster Beverage's (MNST) Q2 Earnings Coming Up: Things to Note
by Zacks Equity Research
Monster Beverage's (MNST) second-quarter 2024 results are likely to reflect gains from strength in its energy drinks category and product launches.
B&G Foods' (BGS) Q2 Earnings in the Cards: Factors to Watch
by Zacks Equity Research
B&G Foods' (BGS) Q2 results are likely to reflect the impacts of category-wide challenges across the food industry and high SG&A costs.
Can Molson Coors' (TAP) Strategies Outrun Inflation Woes in Q2?
by Zacks Equity Research
Molson Coors' (TAP) strategic investments and premiumization efforts drive robust growth amid industry challenges and inflationary pressures. Let us see how the Q2 performance is likely to have been.
Medifast (MED) Q2 Earnings in the Cards: Factors to Watch
by Zacks Equity Research
Medifast's (MED) Q2 results are likely to reflect customer acquisition challenges stemming from the growth of GLP-1 medications in markets.
Factors to Watch Before TreeHouse Foods' (THS) Q2 Earnings
by Zacks Equity Research
TreeHouse Foods' (THS) Q2 results are likely to reflect challenges such as the restart of the broth facility, along with the lag in pricing adjustments to counter cocoa inflation.
Kellanova (K) Q2 Earnings Coming Up: Key Factors to Consider
by Zacks Equity Research
Kellanova's (K) second-quarter performance is likely to reflect the impacts of elevated inflation rates and industry-wide elasticities. Unfavorable foreign currency rates pose a threat.
What's in Store for Church & Dwight's (CHD) Q2 Earnings Report?
by Zacks Equity Research
Church & Dwight's (CHD) robust portfolio built through innovation, new products, and acquisitions positions it well for Q2 earnings amid escalated marketing expenses and inflationary headwinds.
Tyson Foods (TSN) Q3 Earnings in the Cards: Things to Note
by Zacks Equity Research
Tyson Foods (TSN) Q3 performance will likely reflect gains from growing protein demand. However, a tight cattle supply environment might have been a spoilsport.